BonacaMPBhattDLCohenM, et al.Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med2015; 372: 1791–1800.
2.
BonacaMPStoreyRFTherouxP, et al.Efficacy and safety of ticagrelor over time in patients with prior MI in PEGASUS–TIMI 54. J Am Coll Cardiol2017; 70: 1368–1375.
3.
WallentinLBeckerRCBudajA, et al.Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med2009; 361: 1045–1057.
4.
UlvenstamAHenrikssonRSöderströmL, et al.Ischemic stroke rates decrease with increased ticagrelor use after acute myocardial infarction in patients treated with percutaneous coronary intervention. Eur J Prev Cardiol2018; 25: 1219–1230.
5.
Tóth-ZsámbokiEHorváthZHajtmanL, et al.Cardiac rehabilitation programme as a non-pharmacological platelet inhibitory tool in acute coronary syndrome survivors. Eur J Prev Cardiol2017; 24: 1148–1156.
6.
BavishiCTrivediVSinghM, et al.Duration of dual antiplatelet therapy in patients with an acute coronary syndrome undergoing percutaneous coronary intervention. Am J Med2017; 130: 1325.e1–1325.e12.
7.
YehRWSecemskyEAKereiakesDJ, et al.Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention. JAMA2016; 315: 1735–1749.
8.
BlinPDureau-PourninCLassalleR, et al.Outcomes in patients after myocardial infarction similar to those of the PEGASUS–TIMI 54 trial: a cohort study in the French national claims database. Br J Clin Pharmacol2017; 83: 2056–2065.
9.
D'Ascenzo F, Bertaina M, Fioravanti F, et al. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: insights from the RENAMI registry. Eur J Prev Cardiol. 2020; 27: 696–705.
10.
Levine GN, Bates ER, Bittl JA, et al. ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2016; 68: 1082–1115.
11.
CostaFvan KlaverenDJamesS, et al.Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE–DAPT) score: a pooled analysis of individual–patient datasets from clinical trials. Lancet (Lond Engl.)2017; 389: 1025–1034.
